PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
16.78%
Revenue growth above 1.5x AVGO's 6.32%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
15.87%
Gross profit growth above 1.5x AVGO's 4.96%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
17.31%
Positive EBIT growth while AVGO is negative. John Neff might see a substantial edge in operational management.
17.31%
Operating income growth above 1.5x AVGO's 1.00%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
16.33%
Positive net income growth while AVGO is negative. John Neff might see a big relative performance advantage.
16.18%
Positive EPS growth while AVGO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
16.42%
Positive diluted EPS growth while AVGO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.18%
Share reduction while AVGO is at 0.15%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.30%
Reduced diluted shares while AVGO is at 0.70%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.22%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
21.67%
OCF growth above 1.5x AVGO's 9.32%. David Dodd would confirm a clear edge in underlying cash generation.
24.45%
FCF growth above 1.5x AVGO's 9.56%. David Dodd would verify if the firm’s strategic investments yield superior returns.
2457.03%
10Y revenue/share CAGR above 1.5x AVGO's 416.86%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
1057.66%
5Y revenue/share CAGR above 1.5x AVGO's 134.28%. David Dodd would look for consistent product or market expansions fueling outperformance.
403.10%
3Y revenue/share CAGR above 1.5x AVGO's 62.33%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
7201.40%
10Y OCF/share CAGR above 1.5x AVGO's 580.47%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
968.99%
5Y OCF/share CAGR above 1.5x AVGO's 92.77%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
1082.05%
3Y OCF/share CAGR above 1.5x AVGO's 39.51%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
9870.55%
Net income/share CAGR above 1.5x AVGO's 869.72% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
2036.19%
5Y net income/share CAGR above 1.5x AVGO's 414.43%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
698.24%
3Y net income/share CAGR above 1.5x AVGO's 16.00%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
1299.84%
10Y equity/share CAGR above 1.5x AVGO's 862.23%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
484.46%
5Y equity/share CAGR above 1.5x AVGO's 165.61%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
182.07%
3Y equity/share CAGR similar to AVGO's 201.93%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
374.95%
Below 50% of AVGO's 1405.93%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
151.21%
5Y dividend/share CAGR above 1.5x AVGO's 71.84%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
149.56%
3Y dividend/share CAGR above 1.5x AVGO's 38.22%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
25.20%
Our AR growth while AVGO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
14.67%
Inventory growth well above AVGO's 8.08%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
12.66%
Asset growth above 1.5x AVGO's 0.60%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
13.52%
BV/share growth above 1.5x AVGO's 5.15%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
2.10%
We have some new debt while AVGO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
9.71%
R&D growth drastically higher vs. AVGO's 13.26%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
6.53%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.